Loading clinical trials...
Loading clinical trials...
Respiratory changes in aortic blood velocity have been described as an indicator of fluid responsiveness when measured in the left ventricular outflow tract by trans esophageal echography. A threshold value of 12% allowed discrimination between responders and nonresponders with a sensitivity of 100% and a specificity of 89%. The suprasternal window is already used to measure cardiac output. The primary endpoint of this study is to determine the predictive value of the respiratory variability in aortic blood velocity measured by suprasternal view (∆VpicSS) as an indicator of fluid responsiveness. The secondary endpoint is to compare maximum velocity and velocity time integral measured by suprasternal and transthoracic view.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Hopital de la Croix-Rousse, Hospices Civils de Lyon
Lyon, France
Start Date
April 1, 2015
Primary Completion Date
March 1, 2016
Completion Date
March 1, 2016
Last Updated
June 7, 2016
62
ACTUAL participants
Fluid challenge with 250 ml of Ringer Lactate
DEVICE
Lead Sponsor
Hospices Civils de Lyon
NCT07061093
NCT06652425
NCT06663267
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions